Jazz Pharmaceuticals plc Restructuring Charges
Jazz Pharmaceuticals plc (JAZZ) reported Restructuring Charges of $1.64 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2016-02-23
- Jazz Pharmaceuticals plc restructuring charges for the quarter ending 2013-12-31 was $0.00.
- Jazz Pharmaceuticals plc restructuring charges for fiscal 2015 was $1.64M, a 15.46% decline from fiscal 2014.
- Jazz Pharmaceuticals plc restructuring charges for fiscal 2014 was $1.94M, a 33.22% increase from fiscal 2013.
- Jazz Pharmaceuticals plc restructuring charges for fiscal 2013 was $1.46M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|
| 2015-12-31 | $1.64M 10-K · filed 2016-02-23 | ||
| 2014-12-31 | $1.94M 10-K · filed 2016-02-23 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $1.46M 10-K · filed 2016-02-23 | |
| 2013-09-30 | $1.46M 10-Q · filed 2013-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |